ARCHIVES

Pharmacia Says SU5416 Doesn’t Benefit Colorectal Cancer Patients, Closes Trial.

This article is from The Cancer Letter archive.

Vol. 28 No. 09 | March 1, 2002

Download PDF Visit The Full Archive

Related Articles

Hammer Gives $100,000 to Expand Rosenberg’s T-Cell Growth Factor Clinical Studies

March 1, 1985

Second-Generation CML Drugs Show Promise For Frontline

December 26, 2008

Mozobil Plus G-CSF Increases Rate Of Cell Mobilization

September 30, 2005

Regions Outlined In CIS Proposal

May 31, 1991

NCI Could Fund 840 Competing Grants Under Clinton Budget

April 16, 1993

Improved Therapies For Cervical Cancer Said To Show Promise In Clinical Trials

March 26, 2004